SG Americas Securities LLC Purchases 53,443 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)

SG Americas Securities LLC boosted its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 195.2% in the first quarter, Holdings Channel.com reports. The firm owned 80,825 shares of the company’s stock after acquiring an additional 53,443 shares during the period. SG Americas Securities LLC’s holdings in Health Catalyst were worth $366,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets bought a new position in Health Catalyst during the 4th quarter worth about $735,000. Wells Fargo & Company MN grew its holdings in shares of Health Catalyst by 27.3% in the 4th quarter. Wells Fargo & Company MN now owns 39,355 shares of the company’s stock valued at $278,000 after acquiring an additional 8,451 shares in the last quarter. Two Sigma Investments LP bought a new position in shares of Health Catalyst in the 4th quarter valued at about $496,000. Raymond James Financial Inc. bought a new position in shares of Health Catalyst in the 4th quarter valued at about $2,044,000. Finally, Northern Trust Corp grew its holdings in shares of Health Catalyst by 8.5% in the 4th quarter. Northern Trust Corp now owns 526,607 shares of the company’s stock valued at $3,723,000 after acquiring an additional 41,298 shares in the last quarter. Institutional investors own 85.00% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on HCAT. Stifel Nicolaus raised their price objective on Health Catalyst from $5.00 to $5.50 and gave the company a “hold” rating in a report on Thursday, May 8th. Citigroup decreased their price objective on Health Catalyst from $7.00 to $6.50 and set a “buy” rating for the company in a report on Friday, April 25th. Evercore ISI cut Health Catalyst from an “outperform” rating to an “inline” rating in a report on Wednesday, April 9th. Royal Bank Of Canada reduced their price target on Health Catalyst from $7.00 to $6.00 and set a “sector perform” rating for the company in a report on Thursday, February 27th. Finally, KeyCorp reduced their price target on Health Catalyst from $7.00 to $5.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Health Catalyst presently has a consensus rating of “Moderate Buy” and a consensus price target of $8.00.

Health Catalyst Stock Up 0.8%

Shares of HCAT opened at $3.77 on Thursday. Health Catalyst, Inc. has a one year low of $3.49 and a one year high of $9.24. The company has a market cap of $262.39 million, a P/E ratio of -3.28 and a beta of 1.53. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.24 and a quick ratio of 1.24. The firm has a 50 day simple moving average of $3.92 and a two-hundred day simple moving average of $4.97.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.